BACKGROUND Thrombosis is an uncommon, but severe complication of left ventricular assist devices (LVADs).
Events involving blood flow abnormalities were identified using our institutional database and clinical and technical files and classified as high-power and low-flow events, according to the alarms generated from the pump. "High power" was defined as a power increase that generated a high-power alarm (alarm threshold commonly set at 1 W above mean power consumption) or a power trend increase of more than 0.5 W above the 30-day peak values. "Low flow" was defined as a decrease of >2 l/min below patient-specific average value, with a distinction made between persistent immediate decrease and continuous slow decrease.
The alarms triggered by these derangements are "high-power alarm" and "low-flow alarm" and are easily detected by the patients themselves. Low-flow events caused by hypovolemia (bleeding or dehydration), hypertension, and arrhythmia were excluded from the analysis. All alarm events were managed by the VAD coordinator. Anticoagulation was performed as described pre- For the definition of hemolysis we used a threshold of 20 mg/dl plasma-free hemoglobin, which is lower than reported previously (5) and is used by the Interagency Registry for Mechanically Assisted Circulatory Support (6). We measure hemoglobin, total bilirubin, plasma-free hemoglobin, lactate dehydrogenase, and haptoglobin routinely during every outpatient visit and advise the general practitioners who care for these patients to do so too.
Analysis of actual flow curves, log-files of technical data downloaded from the controller, and the acoustic spectra was performed in all patients before discharge home, during outpatient visits, and in every case of blood flow abnormalities, as described elsewhere (7). Lavare cycle is routinely enabled on first day after implantation in all patients; it does not affect the log-file interpretation because of the presence of a blanking algorithm in the log-file viewer.
Acoustic signal analysis has been part of our routine practice in the past 3 years (7). 
Pre-, Intra-, and Post-Pump Thrombosis Re-evaluation after correction
The figure explains our strategy in managing LVAD pump thrombosis. In the first part, in pink, the steps for the detection of blood flow obstruction through the system are outlined. In the second part, in blue, the steps for treatment are presented. Pump flow could be disturbed at different levels of the left ventricular assist device system. Numbers indicate the site of thrombus apposition and identify the types of pump thrombosis. Number 1, pre-pump thrombosis. Number 2, intra-pump thrombosis. Number 3, post-pump thrombosis at the level of outflow graft and aortic anastomosis. Pre-, Intra-, and Post-Pump Thrombosis J U N E 1 4 , 2 0 1 6 : 2 7 5 8 -6 8
For occlusive thrombus of the inflow cannula, we recently developed a noninvasive technique to "wash Forty-three patients received heart transplantation and 12 were weaned from the device following myocardial recovery.
Survival after event for patients who experienced thrombosis of the device was 69.7% at 30 days, and Kaplan-Meier curve of survival of the whole population for 1, 2, and 3 years is shown.
Patients at risk and confidence bounds are indicated below the curve. Patients who were weaned or transplanted are also included. Survival of patients with multiple device placements starts at the time of first placement only. Acoustic analysis was positive in all cases (100%).
Intra-pump obstruction was treated by thrombolysis in 9 patients (3 successful; success rate, 33%), pump exchange in 53 cases (49 successful; success rate, 94%), and removal for myocardial recovery (3 cases; success rate, 100%). Seven patients died (too sick for surgery or refused surgery) and in 2 cases the parameters spontaneously normalized.
POST-PUMP THROMBOSIS. Post-pump obstruction by thrombus inside the outflow graft or secondary to stenosis of the aortic anastomosis occurred in 4 patients (4%; 0.006 EPPY). Median support duration until first event was 644 days (IQR: 278 to 934 days).
Post-pump obstruction was treated by stenting (2 cases; success rate, 100%) or left untreated (2 cases).
Based on this experience we developed an algorithm ( Figure 1) for the diagnosis and treatment of blood flow abnormalities during support with the LVAD. later lysis is a viable option, but the success rate was lower (56%). The 4 patients in whom lysis failed then underwent washout maneuver (n ¼ 2) and pump exchange (n ¼ 2).
In the past, pump exchange was performed for prepump flow obstruction. For the past 3 years, however, we have regarded the washout maneuver as first choice. For 1 year it has been routinely performed with a cerebral protection system. Therefore, our overall treatment results are influenced by the introduction of the washout maneuver in our clinical practice.
INTRA-PUMP THROMBOSIS. Because early intervention is key for success, pump exchange is the definitive treatment for intra-pump thrombosis, and thrombolysis plays a secondary role in managing this complication. Technically, an increase of power consumption and detection of the third harmonic are the first signs of LVAD thrombosis. Clinically, hemolysis as a consequence of the unbalanced impeller with subsequent friction and destruction of all blood components is the leading symptom of intra-pump Values are n (%). Gastrointestinal bleeding after lysis was recorded in 1 patient with known angiodysplasia. Recurrence of thrombosis after successful lysis was observed in 4 patients. *Success is defined as restoration of normal blood flow. †With consequent death of the patient. ‡There were multiple treatment attempts.
be clearly visualized with contrast. In this case pressure should be measured along the outflow graft and in the aorta as the next step. A pressure drop between the outflow graft and aorta indicates stenosis. Pressure measurement may be also useful for measuring success after stenting.
Two of our patients were successfully treated with stenting; the others were too critical to undergo treatment, and died within a few days (1 was judged unsuitable for surgery and stenting was not considered; in 1 case the pressure drop was not documented).
Echocardiography may rule out other causes of hemolysis, such as aortic insufficiency. Echo measurement of blood velocity through the outflow graft is feasible and the detection of abnormalities should prompt fluoroscopic assessment of the graft.
We were able to restore normal blood flow in almost all of our patients, in some after 2 or more different attempts. The exceptions were a few patients for whom surgery was not suitable or who declined further treatment. Our overall success rate Furthermore, the detection and management algorithm has evolved through the course of the study as the center learned "best practice." Therefore during the past 6 years our diagnosis and treatment have changed with growing experience. In earlier days, some cases of pre-pump thrombosis were treated by pump exchange, whereas now we attempt the washout maneuver first. Similarly, it is probable that some post-pump thrombosis was not recognized and was treated by pump exchange. 
CONCLUSIONS

